ストックスクリーナーアプリを入手
2.08
5.86%
0.1152
Cocrystal Pharma Inc (COCP) 最新ニュース
Influenza Pipeline Insights, Clinical Trials Analysis, Emerging Therapies and Companies | DelveInsight - EIN News
**Cocrystal Pharma, Inc. Presents Corporate Update to Investment Community** - Defense World
Midday Market Movers: Biggest Stock Declines of the Day – Market - HPBL
Cocrystal Pharma Engages Investors with Limited Disclosure - TipRanks
Cocrystal Pharma Reports Positive Phase 1 Results with Oral Pan-Viral Protease Inhibitor CDI-988 for Norovirus and Coronavirus Infections - Defense World
Cocrystal Pharma Extends Phase 2a Influenza Drug Study Amid Lower Infection Rates, Stock Near 52-Week High - HPBL
COCP: Phase 2a Trial of CC-42344 Extended - Smartkarma
COCP: Phase 2a Trial of CC-42344 Extended… - Zacks Small Cap Research
Cocrystal Pharma Reports Positive Phase 1 Study Results - TipRanks
Cocrystal Pharma Reports Phase 1 Results with Oral, - GlobeNewswire
Cocrystal Pharma Reports Phase 1 Results with Oral, Broad-Acting Antiviral Drug CDI-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections - Yahoo Finance
Nuveen New York Quality Municipal Income Fund Announces Key Board ChangesOn December 31, 2024, Nuveen New York Quality Municipal Income Fund (NYSE:NAN) submitted a Form 8-K filing with the Securities and Exchange Commission detailing not - Defense World
CLS Holdings USA, Inc. Executes Agreement to Amend Convertible Debentures - Defense World
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Sees Large Growth in Short Interest - Defense World
BRC Inc. (NYSE: BRCC) Amends Credit Agreements and Enters into $40 Million Term Loan Facility - Defense World
A SPAC III Acquisition Corp Announces Agreement with HD Education Group Limited - Defense World
Supermarket Income REIT (OTCMKTS:SUPIF) Shares Up 0.7% – Should You Buy? - Defense World
Cornish Metals (LON:CUSN) Shares Up 1.1% – What’s Next? - Defense World
Greenwave Technology Solutions (NASDAQ:GWAV) Stock Price Down 3.9% – Here’s What Happened - Defense World
Cocrystal Pharma, Inc. to Extend Phase 2a Influenza Challenge Study with Oral PB2 Inhibitor CC-42344 - Marketscreener.com
Dow Dips Over 100 Points; Cocrystal Pharma Shares Slide - Benzinga
Cocrystal Pharma Shares Drop 35% Following Phase 2a Study Extens - GuruFocus.com
Cocrystal Pharma Shares Drop 35% Following Phase 2a Study Extension Announcement - GuruFocus.com
Stock market news: Coeptis Therapeutics Holdings -96.03%, OptiNose -93.07% among biggest losers during mid day trading - Business Upturn
Cocrystal stock plunges 40% on influenza drug update - MSN
Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet - Benzinga
Cocrystal stock plunges 40% on influenza drug update (COCP:NASDAQ) - Seeking Alpha
US Stocks Open Higher; House Prices Increase In October - Benzinga
Equitable Holdings, Inc. (NYSE: EQH): Insider Trades, Institutional Moves, and Market Momentum - HPBL
Alexander, Inc. (NYSE: ALX): A Deep Dive into Rising Short Interest, Dividends, and Institutional Activity - HPBL
EQT Corporation: A Deep Dive into the Natural Gas Giant Performance and Market Insights – News - HPBL
Cocrystal Pharma Extends Enrollment for Influenza Study - TipRanks
Cocrystal Pharma Shares Fall After Flu-Treatment Study Is Extended - MarketWatch
Carter, Inc. Faces Growing Short Interest and Market Dynamics in December 2024 – News - HPBL
Canoo Downgraded by Stifel Amid Rising Liquidity Risks and Operational Challenges – News - HPBL
Wall Street holiday: When are Nasdaq, NYSE shut for trading on account of New year’s holiday- December 31 or January 1? | Stock Market News - Mint
Cocrystal Pharma extends trial due to low flu infection rate - Investing.com
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344 - GlobeNewswire
Cocrystal Pharma Extends Phase 2a Flu Drug Trial Despite Strong Safety Profile, Low Infection Rates Challenge Study - StockTitan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Short Interest in Cocrystal Pharma, Inc. (NASDAQ:COCP) Increases By 150.0% - Defense World
Falcon’s Beyond Global, Inc. (NASDAQ:FBYD) Short Interest Up 157.7% in December - Defense World
Astellas Pharma Inc. (OTCMKTS:ALPMY) Short Interest Up 150.7% in December - Defense World
COCP stock touches 52-week high at $3.1 amid market optimism - Investing.com Canada
Athira Pharma (NASDAQ:ATHA) Stock Quotes, Forecast and News Summary - Benzinga
Fmr LLC Buys 2,445 Shares of Kearny Financial Corp. (NASDAQ:KRNY) - Defense World
Prada (OTCMKTS:PRDSF) Share Price Crosses Above Two Hundred Day Moving Average – Should You Sell? - Defense World
MetLife (NYSE:MET) Downgraded by StockNews.com to Hold - Defense World
US Penny Stocks To Watch In December 2024 - Yahoo Finance
Detection of Hydrogen Atoms Using Only 3D ED/MicroED and Contribution to Structure Determining Salts or Cocrystals - ACS Publications
Robert W. Baird Boosts Bloom Energy (NYSE:BE) Price Target to $32.00 - Defense World
Cocrystal Pharma (FRA:8CC) Price-to-Operating-Cash-Flow : (As of Dec. 04, 2024) - GuruFocus.com
Influenza Pipeline Therapeutics Assessment Report 2024 (Updated) - openPR
Hepatitis C Virus Infection Pipeline Forecast 2024: FDA - openPR
Cocrystal Pharma (STU:8CC) Earnings Yield % : N/A% (As of Nov. 26, 2024) - GuruFocus.com
Cocrystal Pharma (STU:8CC) 14-Day RSI : 67.70 (As of Nov. 20, 2024) - GuruFocus.com
Cocrystal Pharma (STU:8CC) GF Value Rank : 10 (As of Nov. 20, 2024) - GuruFocus.com
0.81%
7.69%
大文字化:
|
ボリューム (24 時間):